CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTMX CytomX

盘前交易 07-24 04:07:14 EDT

1.44

-0.01

-0.69%

最高1.48	最低1.40	成交量71.56万
今开1.42	昨收1.45	日振幅5.52%
总市值1.12亿	流通市值8,408万	总股本7,792万
成交额103.73万	换手率1.23%	流通股本5,839万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTMX","market":"US","secType":"STK","nameCN":"CytomX","latestPrice":1.44,"timestamp":1721764800000,"preClose":1.45,"halted":0,"volume":715615,"delay":0,"floatShares":58385980,"shares":77919369,"eps":0.212633,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.01,"latestTime":"07-24 04:07:14 EDT","open":1.42,"high":1.48,"low":1.4,"amount":1037324.8041165001,"amplitude":0.055172,"askPrice":2.3,"askSize":200,"bidPrice":1.35,"bidSize":1,"shortable":3,"etf":0,"ttmEps":0.212633,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721827800000},"adr":0,"listingDate":1444276800000,"adjPreClose":1.44,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.42,"preClose":1.44,"latestTime":"19:19 EDT","volume":737,"amount":1045.58,"timestamp":1721776749937},"volumeRatio":1.3167487483891958,"impliedVol":2.4817,"impliedVolPercentile":0.4183},"requestUrl":"/m/hq/s/CTMX","defaultTab":"news","newsList":[{"id":"2453712373","title":"Cytomx Therapeutics, Inc.盘中异动 下午盘快速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453712373","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453712373?lang=zh_cn&edition=full","pubTime":"2024-07-23 03:21","pubTimestamp":1721676095,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日03时21分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅拉升5.07%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为123.74%、116.51%、85.54%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Mei Pharma, Inc.、木薯科学，振幅分别为44.07%、37.06%、33.41%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723032135af9376c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723032135af9376c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","BK4139","LENZ"],"gpt_icon":0},{"id":"2434906260","title":"Wedbush：上调CytomX Therapeutics(CTMX.US)评级，由中性调整至优于大市评级, 目标价由3.00美元调整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434906260","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434906260?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:15","pubTimestamp":1715260541,"startTime":"0","endTime":"0","summary":"Wedbush：上调CytomX Therapeutics(CTMX.US)评级，由中性调整至优于大市评级, 目标价由3.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092115438aed03f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092115438aed03f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTMX"],"gpt_icon":0},{"id":"2434093784","title":"BUZZ-CytomX Therapeutics 因癌症疗法试验数据遭质疑而下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2434093784","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434093784?lang=zh_cn&edition=full","pubTime":"2024-05-09 19:21","pubTimestamp":1715253672,"startTime":"0","endTime":"0","summary":"    5月9日 - ** CytomX Therapeutics   股价盘前暴跌28.40%至3美元 ** 该公司称  疗法 CX-904 在一项早期研究中对 6 名胰腺癌患者中的 2 人产生了部分反应** 这项研究涉及 35 名不同类型癌症的晚期转移性实体瘤患者** 威廉-布莱尔说，关于疗效的持久性以及为什么没有其他类型的肿瘤出现反应的问题，是中期更新中一直存在的问题。** 杰富瑞表示，投资者的 \"争论\"，如反应持续时间似乎很短、结直肠癌疗效不明显等，都给该公司股票带来了压力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","CTMX","LENZ","BK4139"],"gpt_icon":0},{"id":"2429923385","title":"小摩：上调CytomX Therapeutics(CTMX.US)评级，由减持调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429923385","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429923385?lang=zh_cn&edition=full","pubTime":"2024-04-22 20:25","pubTimestamp":1713788750,"startTime":"0","endTime":"0","summary":"小摩：上调CytomX Therapeutics(CTMX.US)评级，由减持调整至中性评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220255987a1651f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220255987a1651f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ"],"gpt_icon":0},{"id":"2418809259","title":"CytomX Therapeutics Inc    预计每股亏损 3 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2418809259","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2418809259?lang=zh_cn&edition=full","pubTime":"2024-03-09 04:17","pubTimestamp":1709929059,"startTime":"0","endTime":"0","summary":"   * CytomX Therapeutics Inc    将于3月11日公布截至2023年12月31日的季度财报，预计该公司的季度收入将有所增长。* LSEG 分析师对 CytomX Therapeutics Inc 的平均预期是每股亏损 3 美分。* 华尔街对 CytomX Therapeutics Inc 的 12 个月目标价中位数为 3.00 美元，高于其最新收盘价 2.56 美元。3月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTMX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cytomx.com","stockEarnings":[{"period":"1week","weight":-0.0464},{"period":"1month","weight":0.1163},{"period":"3month","weight":-0.1166},{"period":"6month","weight":-0.0588},{"period":"1year","weight":-0.1771},{"period":"ytd","weight":-0.071}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.017},{"period":"3month","weight":0.0957},{"period":"6month","weight":0.1347},{"period":"1year","weight":0.2192},{"period":"ytd","weight":0.1651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CytomX Therapeutics, Inc.于2010年9月在特拉华州注册成立。该公司是一家临床阶段、专注于肿瘤学的生物制药公司，专注于开发旨在定位于肿瘤微环境的新型条件激活生物制剂。该公司专有、多功能、多模态的PROBODY技术平台旨在使肿瘤微环境内的生物治疗候选药物能够有条件地激活，同时最大限度地减少健康组织和循环中的药物活性。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.098508},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.007093},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.031361},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.028412},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.068706},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.024186},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.044906},{"month":8,"riseRate":0.5,"avgChangeRate":0.006397},{"month":9,"riseRate":0.25,"avgChangeRate":-0.027106},{"month":10,"riseRate":0.25,"avgChangeRate":-0.082803},{"month":11,"riseRate":0.777778,"avgChangeRate":0.189115},{"month":12,"riseRate":0.555556,"avgChangeRate":0.008351}],"exchange":"NASDAQ","name":"CytomX","nameEN":"CytomX Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CytomX(CTMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CytomX,CTMX,CytomX股票,CytomX股票老虎,CytomX股票老虎国际,CytomX行情,CytomX股票行情,CytomX股价,CytomX股市,CytomX股票价格,CytomX股票交易,CytomX股票购买,CytomX股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CytomX(CTMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况